Presentation Includes Discussion of Monetization of NurseMagic™ DETROIT, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today it will release an end of year video shareholder update to its website today, December 23, 2024 at 3:00 pm ET. The presentation wil...
Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in Healthcare Company Dramatically Increasing Its Reach and Engagement as It Scales B2C and B2B Sales with AI-First Solution in Healthcare
Company Generating Recurring Revenue in $330 Billion Revenue Home Health and Home Care Industries Company Generating Recurring Revenue in $330 Billion Revenue Home Health and Home Care Industries
Company Offers Affordable App Targeting 5.2 Million U.S. Nurses and Dozens of Other Professions Company Offers Affordable App Targeting 5.2 Million U.S. Nurses and Dozens of Other Professions
DETROIT, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today its Founder and CEO, Dr. Ann Marie Sastry, was featured as a guest speaker at the Lesher Foundation's Newsmakers: 24/25 Season on October 24, 2024, following Former U.S. Representative Liz Cheney...
Dramatically Increases the Number of Workers and Professions Who Can Benefit from NurseMagic™ Dramatically Increases the Number of Workers and Professions Who Can Benefit from NurseMagic™
Company's NurseMagic™ Solution Adopted Across Nation, Shown to Address Home Health Care Market Pain Company's NurseMagic™ Solution Adopted Across Nation, Shown to Address Home Health Care Market Pain
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.